Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...
Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with ...
A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...
Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
This model exhibits ... New Method Predicts Worsening of Chronic Kidney Disease Sep. 12, 2024 — Researchers have developed a new method that could be a significant step in the treatment of ...
Organ donation registration can be completed through the Ohio Bureau of Motor Vehicles. Living donors can contact one of two ...
The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback